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W HY don’t physicians follow clinical practice guidelines? This question was asked by Cabana et al.1 15 yr ago 
and continues to be a concern in health care today. The bar-
riers to adherence to published clinical guidelines at that time 
were noted to be multifactorial, and numerous reports show 
that these barriers to adherence still exist, with poor adherence 
to guidelines being associated with poor patient outcomes and 
concerns for patient safety.2–19 Recommendations concerning 
methods that might help mitigate barriers include the use of 
checklists and decision support systems.20
The 2010 American Society of Regional Anesthesia and 
Pain Medicine (ASRA) consensus statement on regional 
What We Already Know about This Topic
•	 Adoption	 and	 correct	 application	 of	 evidence-based	 guide-
lines	are	often	delayed	and	incomplete
•	 In	other	specialties,	electronic	decision	support	tools	improve	
adherence	to	practice	guidelines	or	protocols
What This Article Tells Us That Is New
•	 In	 this	 multicenter,	 randomized	 trial	 of	 more	 than	 250	 resi-
dents	and	faculty,	use	of	an	electronic	decision	support	tool	
improved	 adherence	 to	 guidelines	 in	 a	 testing	 environment	
regarding	regional	anesthesia	and	anticoagulation	compared	
with	a	control	group	who	could	 freely	access	 the	guidelines	
and	any	other	cognitive	aid
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ABSTRACT
Background: The American Society of Regional Anesthesia and Pain Medicine (ASRA) consensus statement on regional 
anesthesia in the patient receiving antithrombotic or thrombolytic therapy is the standard for evaluation and management 
of these patients. The authors hypothesized that an electronic decision support tool (eDST) would improve test performance 
compared with native physician behavior concerning the application of this guideline.
Methods: Anesthesiology trainees and faculty at 8 institutions participated in a prospective, randomized trial in which they com-
pleted a 20-question test involving clinical scenarios related to the ASRA guidelines. The eDST group completed the test using an 
iOS app programmed to contain decision logic and content of the ASRA guidelines. The control group completed the test by using 
any resource in addition to the app. A generalized linear mixed-effects model was used to examine the effect of the intervention.
Results: After obtaining institutional review board’s approval and informed consent, 259 participants were enrolled and ran-
domized (eDST = 122; control = 137). The mean score was 92.4 ± 6.6% in the eDST group and 68.0 ± 15.8% in the control 
group (P < 0.001). eDST use increased the odds of selecting correct answers (7.8; 95% CI, 5.7 to 10.7). Most control group 
participants (63%) used some cognitive aid during the test, and they scored higher than those who tested from memory alone 
(76 ± 15% vs. 57 ± 18%, P < 0.001). There was no difference in time to completion of the test (P = 0.15) and no effect of 
training level (P = 0.56).
Conclusions: eDST use improved application of the ASRA guidelines compared with the native clinician behavior in a testing 
environment.  (Anesthesiology 2016; 124:186-98)
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anesthesia in the patient receiving antithrombotic or throm-
bolytic therapy (hereafter referred to as ASRA guidelines) is 
the standard for the assessment of patients taking antico-
agulant medications who need to be evaluated for the safety 
of placement and management of regional or neuraxial 
anesthesia blocks (epidural or spinal anesthesia).21 Although 
these evidence-based guidelines are recognized as the stan-
dard for patient management, the complete document and 
executive summary are more than 40 pages long. Thus, it is 
likely that clinicians who perform procedures for regional 
or neuraxial anesthesia are unfamiliar with all of the details 
of the ASRA guidelines and that lack of adherence to these 
guidelines poses a problem for patient care and safety. On 
the basis of the previous work concerning a different major 
clinical guideline, we hypothesized that a smartphone-based 
electronic decision support tool (eDST) would improve 
test performance in the application of the ASRA consen-
sus guidelines; test performance is not patient care, but 
it is a risk-free way of assessing knowledge of the guide-
line.22 Accordingly, we performed a multicenter prospective 
randomized trial investigating the effects of an eDST on 
adherence to the ASRA guidelines concerning regional and 
neuraxial anesthesia for patients receiving anticoagulation 
compared with native physician behavior.
Materials and Methods
After obtaining institutional review board’s approval (Nash-
ville, Tennessee) and informed consent, anesthesiology resi-
dents, fellows, and faculty at 8 university-based institutions 
were recruited through email to participate in a prospective, 
randomized trial in which they completed a  20-question 
multiple-choice question (MCQ) test involving clinical sce-
narios related to the ASRA guidelines. The trial occurred 
from September to December 2013.
Knowledge Test Creation and Validation
The test creation process involved a modified Delphi technique 
that included anesthesiologists, educators, guideline experts, 
and faculty with training in medical board question writing 
from four participating institutions.23–25 The construct of the 
test was assessed for content, response process, and internal 
structure validity.26 The ASRA guidelines cover a range of medi-
cations known to affect coagulation and also the following four 
principal actions performed in regional or neuraxial anesthesia:
1.  Performing the regional or neuaraxial anesthetic 
procedure
2.  Restarting a medication after the procedure
3.  Removing a neuraxial/perineural catheter while an 
anticoagulant is being administered
4.  Restarting an anticoagulant medication after  neuraxial/
perineural catheter removal
In this test creation and evaluation process, each MCQ 
was mapped to a specific portion of the ASRA guidelines, and 
the questions were written such that each one tested a unique 
 medication–action combination (validity source: represen-
tative of test items to knowledge domain and quality of test 
questions). Four faculty not involved with the test creation 
took the test and reviewed the answers in comparison to the 
ASRA guidelines to confirm that there was one clear best 
answer (validity source: quality of questions). Interitem corre-
lation analysis was performed. Because the grading of the quiz 
was objective with a single correct answer for each question 
agreed upon by the group of faculty that evaluated the quiz, 
there was no reliability assessment of grading. The test was not 
used for participant assessment in any pass–fail manner, but 
rather in assessing the effect of the eDST as measured by cor-
rect responses to each question. The stems and MCQs can be 
reviewed in appendix 1.
Electronic Decision Support Tool Creation
The eDST (ASRA Coags©,* ASRA, USA) used in this study 
was programmed on the iOS platform and presented on the 
Apple iPod Touch (Apple, Inc., USA). A subset of the authors 
(M.D.M., W.R.H., R.G., J.M.C., and R.M.S.), in consultation 
with executive board members from ASRA, designed the logic 
of the eDST directly based on the ASRA guidelines. An iOS 
programmer created the code and executable application (Mus-
tard Seed Software, USA). Various screenshots of the eDST can 
be seen in figure 1. Participants had no previous exposure to or 
formal training on use of the eDST before this study. The eDST 
was presented on iPod Touch or iPhone devices used specifi-
cally for this research project so that participants would not have 
access to the eDST before their testing session.
Study Design
Participants were randomly assigned to the eDST or control 
group through the use of a random number generator (see 
fig. 2). Demographic information was collected on partici-
pants, including training level, gender, and age, along with 
survey data concerning clinical experience, self-reported 
confidence in the application of the ASRA guidelines, and 
smartphone use. The eDST group was allowed to complete 
the test using the ASRA Coags© app (copyright 2014, 
Vanderbilt University and the ASRA). The control group was 
allowed to complete the test using any resource other than 
the eDST (e.g., memory, internet, pocket cards). All partici-
pants were given access to an online video presentation after 
enrollment, which included a brief overview (approximately 
10 min) of the ASRA guidelines and the format of the MCQ 
test. The eDST group was also shown an additional 5-min 
overview of the use of the app. Unlimited time was allowed 
* The decision support tool described in this study was developed 
with intramural funds from Vanderbilt University Department of 
Anesthesiology and has since been marketed as an application on 
the Apple Store by the American Society of Regional Anesthesia as 
ASRA Coags©. Any fees collected on the sale of the application go 
to American Society of Regional Anesthesia and Pain Medicine for 
the maintenance and ongoing development of the application and 
to Vanderbilt for recuperation of development fees.
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for participant completion of the test, and time from start to 
completion was recorded.
Multisite compliance and logistics were regulated in the 
Department of Anesthesiology at Vanderbilt University. 
Randomization was implemented using computer-generated 
random numbers and was assigned in blocks of 100 to each 
site with 1 randomization block of 50 based on the training 
level of resident and 1 randomization of block of 50 for fel-
lows/faculty. All participants were excused from active clinical 
duties and asked to silence all pagers and phones during the 
test. Testing of participants was accomplished within a 10-day 
period at each site, and all sites completed the study within a 
4-month period. The programs that participated in the study 
were Vanderbilt University Medical Center (Nashville, Ten-
nessee), Medical University of South Carolina (Charleston, 
South Carolina), University of Kentucky (Lexington, Ken-
tucky), University of North Carolina (Chapel Hill, North 
Carolina), Ohio State University (Columbus, Ohio), Harvard 
University/Brighman and Women’s Hospital (Boston, Massa-
chusetts), University of Chicago (Chicago, Illinois), and Duke 
University (Durham, North Carolina). Participants were 
instructed to select the single best answer for each question. 
The answers given to each item were recorded into a REDCap 
database (REDCap, Vanderbilt University, USA).
Statistical Analyses
The responses to 20 MCQs were treated as binary outcomes 
(correct/incorrect). Because of feedback from test participants 
about the way in which question 17 was interpreted, two 
answers were considered correct for the analysis (see appen-
dix 1). Of note, this did not affect the outcomes of the overall 
model. Recorded covariates included respondent demograph-
ics (age, gender), training level (residents: postgraduate year 1 
to 4 and fellow; faculty: faculty and regional anesthesia faculty), 
Fig. 1. This series of images displays screenshots that a user would encounter when navigating the electronic decision support 
tool (DST). After opening the application, the DST displays an alphabetized list of medications from the American Society of 
Regional Anesthesia and Pain Medicine (ASRA) guidelines along with a search functionality (A). After selecting medication and 
dosing schedule (click 1, B), the user is directed to select the type of block under consideration (click 2, C). In this example, 
“neuraxial block” is selected (red check), and the user is then presented with a choice of actions to perform (click 3, D). In this 
example, the user selects to place the block (red check), which directs the DST to present the conclusion of the ASRA guideline 
(E). Thus, in three clicks, the end user can arrive at the screen presenting the current ASRA guideline for that particular clinical 
situation. By clicking on the ⓘ button (E), the user is presented with choices for obtaining more information (F); in this example, 
this causes the executive summary for this block type, medication, dosing, and action to be presented (G). After the end user 
selects to return to the beginning (restart), or when the user navigates back to the home screen, he or she is given the opportu-
nity to post this anonymous (non–protected health information) data to the ASRA Coags database (H).
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medication category (common: heparin, enoxaparin, warfarin, 
nonsteroidal antiinflammatory drugs and herbals; uncommon: 
others), and other practice characteristics. Participant demo-
graphics were summarized using the sample mean, SD, quartiles, 
and percentages, where appropriate, and stratified by control and 
intervention group. For the primary analysis, generalized linear 
mixed-effects regression model was used to examine the effect of 
intervention on the rate of correct responses, adjusting for age, 
gender, training level, and medication category. As a secondary 
analysis, we further examined the interaction between medica-
tion category and intervention and the interaction between 
question number and intervention. A random intercept was 
used to account for correlation among responses within respon-
dent. Odds ratios (95% CIs) were used to quantify the adjusted 
effect of intervention, and that of each covariate, on the rate of 
correct response. Internal consistency of the test was assessed by 
using Cronbach α coefficient. Finally, a post hoc analysis was per-
formed evaluating the performance of those in the control group 
who reported the use of some form of a cognitive aid and those 
who reported performance from memory alone.
Because no preliminary performance data were avail-
able for the study population, an a priori power analysis 
was not performed. The recruited sample size (eDST = 122; 
control = 137) provided 80% power to detect very subtle 
increases (~0.3 SD units) in the primary outcome, the propor-
tion of correct responses attributable to the use of the eDST, 
assuming two-sided hypothesis testing and an α level of 0.05. 
All analyses were implemented using R 3.0.2 (R Foundation 
for Statistical Computing, Austria). Numerical values are pre-
sented as mean ± SD unless otherwise noted, and a signifi-
cance level of 0.05 was used for statistical inference.
Results
After obtaining institutional review board’s approval 
at all institutions and informed consent, a total of 259 
participants were enrolled and randomized (control = 137; 
eDST = 122). Table  1 displays demographic information. 
The mean percent correct was 92.4 ± 6.6% in the eDST 
group and 68.0 ± 15.8% in the control group (P < 0.001, 
see fig. 3). The eDST group had a higher correct answer rate 
for all questions, and the adjusted odds of a correct answer 
was 7.8-fold greater in the eDST group, relative to control 
(95% CI, 5.7 to 10.7). Time required for test completion 
was not different between groups (control, 22 ± 9 min vs. 
eDST, 21 ± 8 min, P = 0.15). Because of an error with log-
ging of the time function for some participants, 92% of 
participants had data available for analysis (N = 238/259; 
control = 122/137 and eDST = 116/122).
Table 2 shows the model-based effect estimates from the 
primary analysis (the effect of eDST intervention on the pro-
portion of correct answers, adjusting for age, training level, 
and medication category). There was no evidence of train-
ing level (faculty vs. residents, P = 0.56) or medication type 
(common vs. uncommon, P = 0.12) effects, adjusting for 
intervention group and other covariates. There was a signifi-
cant interaction between question number and intervention 
(P < 0.001). However, use of the eDST was associated with 
greater odds of correct response for all questions, relative to 
control, suggesting that the effect of intervention is to con-
sistently improve the rate of correct response. Specifically, 
the effect of intervention was greatest for question 10 (odds 
ratio, 69.7; 95% CI, 7.8 to 620.5) and smallest for ques-
tion 3 (odds ratio, 3.08; 95% CI, 0.5 to 18.9). This effect of 
the eDST was also true in the subset of regional anesthesia 
faculty, with the percent correct answers for regional faculty 
being 94 ± 5% for eDST and 77 ± 13% for control (N = 13 
and = 9, respectively; P < 0.001). Thus, the control regional 
faculty (N = 9) scored on average 10% higher than all other 
control participants (67%). All data sets were complete with 
no ambiguity in answer selection or other potential sources 
Fig. 2. This CONSORT diagram shows how participants 
were recruited, enrolled, allocated, and then analyzed. 
eDST = electronic decision support tool.
Table 1. Demographics
Control 
(N = 137)
eDST 
(N = 122)
Age (yr) 36.2 (11.2) 34.7 (8.4)
Female 47 (34.3) 45 (36.9)
Level of training
  Intern (PGY-1 resident) 3 (2.2) 4 (3.3)
  CA-1 (PGY-2 resident) 25 (18.2) 23 (18.9)
  CA-2 (PGY-3 resident) 29 (21.2) 22 (18.0)
  CA-3 (PGY-4 resident) 26 (19.0) 24 (19.7)
  Fellow 2 (1.5) 5 (4.1)
  Faculty 43 (31.4) 31 (25.4)
  Regional Anesthesia Faculty 9 (6.6) 13 (10.7)
Training
  Resident 85 (62.0) 78 (63.9)
  Faculty 52 (38.0) 44 (36.1)
There were no differences between groups for any comparison. Data are 
represented as n (%), except for age, which is represented as mean (SD).
CA = clinical anesthesia; eDST = electronic decision support tool; 
PGY = postgraduate year.
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of error apparent to the authors. Cronbach α coefficients 
were calculated to be 0.85 ± 0.005, indicating a good level 
of internal consistency for each item and the test as a whole.
Of note, 63% of participants in the control group used 
some (one or more) form of a cognitive aid during the test 
(see table 3), with use of the ASRA website, other websites, 
and pocket cards being reported by 30.7, 24.1, and 18.2% of 
the control group, respectively. Of note, only 9.5% reported 
actually referencing the full ASRA consensus guideline publi-
cation, and a post hoc analysis was performed to assess for any 
effect of the use of a cognitive aid in this group. In the control 
group, those reporting that they used some form of a cognitive 
aid scored significantly better than those who performed from 
memory alone (76 ± 15% vs. 57 ± 18%, P  <  0.001, respec-
tively). When compared with both these groups (control + 
cognitive aid and control − memory alone), those in the eDST 
group performed significantly better (P < 0.01, see fig. 4).
In the pretest survey, the majority of respondents in both 
groups reported that the most frequently accessed reference 
that they referenced in the clinical setting being tested was 
a copy of the ASRA guidelines accessed through the Inter-
net. Also, an overwhelming majority of participants reported 
feeling confident in their ability to apply the guidelines 
Fig. 3. This graph illustrates the effect of the electronic decision support tool (eDST) on performance compared with native be-
havior for each question and overall. The eDST significantly improved overall performance and performance for each question, 
except for question 3 where the scoring for both eDST and control was more than 95% correct. The error bars for the overall 
mean show the SD for each group across the entire test. Data are shown as mean ± 95% CI.
Table 2. Effect of Covariates and Intervention on the Odds of 
Answering Correctly
Components Assessed in  
Multivariable Model OR CI P Value
Participant age 0.99 0.97–1.01 0.144
Faculty 0.88 0.58–1.34 0.56
Uncommon medication 1.14 0.97–1.35 0.12
Intervention (eDST) 7.59 5.54–10.41 <0.001
This table displays an analysis of the recorded covariates in the general-
ized linear mixed-effects regression model. For the primary analysis, gen-
eralized linear mixed-effects regression was used to examine the effect of 
intervention on the rate of correct responses, adjusting for age, training 
level, and medication category, which is shown here as the average odds 
ratio of obtaining a correct answer when the covariate is considered as well 
as when the eDST was used.
eDST = electronic decision support tool; OR = odds ratio.
Table 3. Utilization of Reference Aid by Type in the Control 
Group (N = 137)
Control, N (%)
Memory alone (no reference) 51 (37.2)
ASRA website 42 (30.7)
Other website 33 (24.1)
Smartphone App 6 (4.4)
Pocket card 25 (18.2)
ASRA publication 13 (9.5)
Other 3 (2.2)
This table details the use of reference aids by the control group, which 
should depict native behavior by physicians. Of note, approximately 63% 
of participants in this group used some reference aid when completing the 
test (86/137), with some participants reporting that they used more than 
one cognitive aid.
ASRA = American Society of Regional Anesthesia and Pain Medicine.
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concerning when to place a neuraxial block or remove a cath-
eter relative to anticoagulant dosing (84 and 79%, respec-
tively); and 62% of participants in the control group reported 
feeling confident that they could adhere to the ASRA guide-
lines concerning when to restart an anticoagulant after 
placing or removing a catheter. See appendices 2, 3, and 4 
for complete details from the survey, including confidence 
in guideline application, data concerning familiarity with 
smartphones, and the frequency with which medical software 
or eDSTs are used by participants in a routine practice.
Discussion
Why don’t physicians follow clinical practice guidelines? 
This has been asked for almost two decades, and it remains a 
problem today. It has been suggested that summary checklists 
and decision support tools (DSTs) might improve the correct 
application of consensus guidelines.20 Accordingly, our study 
addressed whether an eDST designed to present the ASRA 
guidelines to physicians could improve performance in the 
application of guidelines in a variety of clinical scenarios pre-
sented as a MCQ test. Our group has recently shown that an 
eDST similar to the one in this study improves performance 
concerning the application of consensus guidelines for the 
preoperative cardiac evaluation of patients undergoing non-
cardiac surgery.22 However, it should be noted that our previ-
ous study investigated the effects of the DST compared with 
the effects of memory alone, whereas in this study, we allowed 
participants in the control group to use any resource that 
they would normally use when managing a patient receiving 
regional or neuraxial anesthesia who was also getting antico-
agulation. As such, our results advance upon those previous 
results and demonstrate four important findings.
First, the use of an eDST greatly improved performance 
compared with native physician behavior. Poor adherence 
to the ASRA guidelines concerning neuraxial blockade and 
anticoagulation has been demonstrated previously, thus 
highlighting the potential role for an eDST.27 The electronic, 
smartphone-based DST tested in this study (ASRA Coags©) 
improved performance, as measured by MCQ test selections 
consistent with the ASRA guidelines, by an absolute 24% 
(36% relative) compared with performance with native 
physician behavior. In specific, the DST provided a statisti-
cally significant benefit for 19 of the 20 MCQ scenarios (see 
fig. 3), and this effect was equally present for common and 
uncommon medications (table 2). Of note, some cognitive 
aid was associated with better performance than memory 
alone, and the use of the eDST specifically tested in this 
study resulted in better performance than either memory 
alone or the use of other cognitive aids. This finding is sig-
nificant because control group members were instructed to 
take the test using any aid or support tool that they would 
normally use during routine clinical practice. Thus, use of 
the eDST tested in this study resulted in performance supe-
rior to native physician behavior with or without a cognitive 
aid. Because the number of anticoagulant medications rap-
idly increases, our findings demonstrate a simple solution to 
an actual problem.28,29
Second, the effect of the eDST was not dependent on the 
training level. It would seem intuitive that physicians with 
more training and more years of practice experience would 
perform better than those who have yet to graduate from 
residency. However, we did not find any such effect across 
the study population. In a subgroup analysis, it was noted 
that control group Regional Anesthesia faculty scored 10% 
higher than others in the same group, but because of the 
sample size, this was not significant. Several previous studies 
have noted that clinicians at various levels of training and 
years of experience in practice showed no difference in perfor-
mance in both crisis and noncrisis situations when managing 
the event from memory alone, with all groups performing 
poorly.23,24,30–32 These reports, along with our study, speak 
to the fact that some facts may be best recalled and applied 
with the help of a cognitive aid.33–37 Furthermore, this find-
ing may highlight the particular areas of interest where the 
developers of guidelines and DSTs should work together to 
have a significant impact on healthcare delivery.20
Third, the positive effect of the eDST was generalizable 
across a wide range of institutions. Any time when a new 
DST is introduced, its efficacy and uptake will be determined 
by a number of factors, including the usability (design inter-
face), clinician attitude toward the tool, and local culture. In 
addition, the general awareness of a guideline and clinician 
familiarity with the specific content can serve as a barrier to 
implementation.1,20,38 Current recommendations encour-
age local modification of cognitive aids as needed to improve 
usability; mandating the use of such tools cannot guarantee its 
use or efficacy.36,39 Rather, implementation is multifactorial, 
and local factors have been shown to be very important.40,41 
Our study did not specifically test the implementation of the 
Fig. 4. This graph displays an analysis of the effect of an 
electronic decision support tool (eDST) versus any cognitive 
aid or memory alone on test performance, showing that the 
eDST still improved performance even after splitting the con-
trol group into those who used a cognitive aid and those who 
completed the test from memory alone.
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eDST that we describe in a clinical setting. However, because 
usability is one major aspect of implementation of any DST, 
our finding of improved test performance of guidelines across 
a large number of institutions is noteworthy, particularly when 
63% of participants in the control group reported using some 
form of decision support (e.g., Internet, pocket card) during 
the study. That is, the control group used aids with which they 
were already familiar, whereas the intervention group used an 
aid that had just been introduced to them. Good usability of 
the DST is likely because of the fact that we performed an 
iterative design process for the user interface and decision logic 
during the programming of the app, seeking feedback from 
multiple sources, as described elsewhere.42–44
Fourth, self-reported confidence level in application of 
the guidelines being tested varied significantly from actual 
performance. Even though proper knowledge concerning 
the ASRA guidelines was demonstrated only 63% of the 
time by the control group, greater than 75% reported feeling 
confident in their ability to apply the guidelines concerning 
when to place a neuraxial block or remove a catheter relative 
to anticoagulant dosing (see table 2). Understanding the gap 
between reported familiarity with and actual application of 
the guidelines is important.
Taken together, these findings could have great import 
for future paradigms of education and practice of physicians 
and other healthcare providers.33,45 Much literature is emerg-
ing about the need to embed a culture of safety and practice 
concerning checklists, DSTs, and other cognitive aids within 
medical education.35–37 A number of pedagogical approaches 
have been recently shown to improve adherence to guide-
lines in a variety of settings, ranging from team training to 
electronic medical records with embedded DSTs.46–50 We 
report on the effect of a DST deployed on mobile technol-
ogy, a form increasingly used by clinicians and learners.51–54 
This form of active information retrieval and application in 
the workplace is something that our current trainees, who 
are digital natives, adept with these computer techniques, 
expect now and in future practice. Moving away from mem-
orization and into information access and application is a 
strategy that can be ingrained in the training of clinicians 
and one that will possibly improve the use of guidelines.55 
Future studies will need to address this question, and physi-
cians will need to work with national organizations to pro-
duce DSTs that can guide safe patient management, as we 
have done with the ASRA since the creation of this DST as 
an iOS application.
At this point, two particular limitations of this study 
should be noted. First, this study reports the effect of a DST 
on knowledge of guidelines in a structured testing condition 
rather than clinical practice. Second, the tool did not lead to 
perfect performance, and there was some variability in the 
degree of improvement in the rate of correct responses across 
the 20 tested scenarios (i.e., an intervention-by-scenario 
interaction). The latter may be because of limitations in the 
validity of the testing construct, or to other, more nuanced 
factors. Concerning testing construct, one source of vali-
dation is the fact that control group Regional Anesthesia 
faculty scored higher than other control group participants 
by 10%. There are also a variety of reasons in cognitive pro-
cessing/decision-making that explain why physicians do 
not use decision support even when it is available. This is 
most common when physicians (mistakenly) believe that 
they recognize a clinical situation or recall a fact correctly. 
It is not human nature to regularly verify that which we 
already believe to be correct unless there has been significant 
training to do so, such as forced closed loop communica-
tion in the airline or military industries. We suggest that 
what this finding really means, rather than lack of validity 
of the test or procedure, is that human factors engineering 
is an important part of decision support and that simply 
providing a tool with the ability to reach the correct answer 
is insufficient to prevent error with 100% certainty. Future 
research can address both of these limitations by exploring 
the effect of this DST in actual clinical practice or at least 
with in situ simulation replicating clinical encounters.
Conclusions
In summary, use of the eDST significantly improved scores 
on a test of knowledge of the ASRA guidelines for simulated 
scenarios of patients being evaluated for regional anesthesia 
who are taking anticoagulant medications. Because all clini-
cians should attempt to practice evidence-based medicine, 
and because an increasing percentage of the population is 
taking an expanding number of anticoagulant medications, 
these results indicate that it may be time to embrace decision 
support technology for such patients undergoing neuaraxial 
or regional anesthesia. Future research needs to address the 
implementation of such tools in the clinical setting.
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Appendix 1: Multiple-choice Test
Participant ID: _________
Please select the SINGLE BEST answer in line with the Ameri-
can Society of Regional Anesthesia and Pain Medicine (ASRA) 
Management Guidelines for Neuraxial and Regional Anesthe-
sia in the Patient Receiving Antithrombotic or Thrombolytic 
Therapy
1.  A 42-yr-old otherwise healthy, white woman with uterine 
cancer is presenting for a total abdominal hysterectomy. You 
have planned to place a low-thoracic epidural for postoperative 
pain control. She received heparin 5,000 units subcutaneously 
30 min ago, and orders are written for this dose every 12 h. She 
is on no other medications. How long should you wait before 
placement of the epidural?
A) 1 h after last dose
B) 2 h after last dose
C) 4 h after last dose
D)  No contraindication to placing epidural immedi-
ately [C]†
2.  A 68-yr-old Hispanic man is postoperative day 2 from 
thoracotomy for left-sided bleb resection. He has sud-
den new onset of neurologic symptoms and is diagnosed 
with acute ischemic stroke followed by alteplase admin-
istration. The pain service is contacted by the covering 
nurse practitioner because he thought there may be an 
issue with the patient’s thoracic epidural. What is the 
best course of action?
A) Continue current therapy
B) Discontinue epidural catheter immediately
C) Recommend neurologic monitoring every 3 h
D)  No definitive recommendation. Check fibrin-
ogen level to help guide timing of catheter 
removal [U]
3.  A 57-yr-old African American woman is on warfarin for atrial 
fibrillation and is scheduled for a colectomy for diverticulitis. 
Her international normalized ratio (INR) in clinic 2 weeks 
before scheduled surgery date is 2.9. The surgeon would like 
her to receive a thoracic epidural and asks about how to coun-
sel her regarding her warfarin. Which of the following is the 
best course of action?
A)  Hold for 3 days and check for normalized INR on day 
of surgery to ensure it is less than 1.8.
B)  Hold for 5 days and check for normalized INR on 
day of surgery to ensure it is less than 1.5 [C].
C) Hold for 7 days and proceed with epidural.
D)  Hold night before surgery and check INR on day of 
surgery to ensure it is less than 1.5.
4.  A thoracic epidural is placed preoperatively without com-
plication for an open abdominal aorta aneurysm repair in a 
72-yr-old white man. How long before systemic hepariniza-
tion (intravenous unfractionated heparin) can be given after 
placement of the epidural?
A) Minimum of 30 min
B) Minimum of 1 h [C]
C) Minimum of 2 h
D) Minimum of 3 h
5.  A 66-yr-old white man presents on the morning of surgery for 
a total hip arthroplasty, and you plan to place a lumbar plexus 
catheter. He had a drug-eluting stent placed 12 months ago. 
He had intolerable side effects from clopidogrel and prasugrel 
and has thus been receiving ticlopidine for antiplatelet therapy. 
How long should he be off his ticlopidine before placement of 
the block?
A) 3 days
B) 7 days
C) 14 days [U]
D) 21 days
6.  A 74-yr-old African American man comes to the postanesthe-
sia care unit with a lumbar epidural after a large lower extrem-
ity free-flap plastic surgery procedure. The plan is to leave the 
epidural in place for 3 to 4 days. When performing postop-
erative pain rounds, you notice an order for 40 mg enoxaparin 
subcutaneously every 24 h. What do you do?
A)  Give first dose of enoxaparin 8 h postoperatively 
and second dose at least 24 h later. Epidural cath-
eter can be safely maintained [C].
B)  Discuss safety concern of this dosing regimen with 
surgical team and recommend 30 mg enoxaparin sub-
cutaneously every 12 h instead.
C)  Give first dose of enoxaparin 4 h postoperatively and 
second dose 24 h later. Epidural catheter can be safely 
maintained.
D)  For safety reasons with this dosing regimen, remove 
epidural immediately and wait 12 h for enoxaparin 
dosing.
7.  A 65-yr-old white man with coronary artery disease and his-
tory of drug-eluting right coronary artery stent placement 12 
months ago presents for exploratory laparotomy for colorectal 
carcinoma resection. He stopped his clopidogrel 6 days ago. 
An epidural is planned for postoperative pain control. Which 
of the following is the proper management?
A)  Postpone the case until the patient has been off clopi-
dogrel for 10 days.
B)  Proceed with case as patient has been off clopidogrel 
for more than 5 days.
C)  As patient has been off clopidogrel 5 to 7 days, 
delay surgery to assess whether platelet function 
is normal [C].
D)  Postpone the case until the patient has been off clopi-
dogrel for 14 days.
† [C] or [U] was not included on the test when given. This notation 
is to show how the question was included in the covariate analysis 
of common [C] versus [U] medications. Also, the correct answer is in 
bold, but this was in standard font when the test was given.
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8.  A 78-yr-old white man with history of systolic heart failure 
(ejection fraction 27% on recent echocardiogram), uncon-
trolled diabetes, and multiple deep vein thromboses presents 
for placement of intertrochanteric screw after a right hip frac-
ture yesterday. He has a history of heparin-induced throm-
bocytopenia after treatment for a pulmonary embolus a year 
ago. He was placed on argatroban for deep vein thrombosis 
prophylaxis last night and is presenting for surgery this morn-
ing. He requests a spinal for his anesthesia. What is the guide-
line recommendation concerning placement of a spinal for 
this patient?
A) Neuraxial technique is not recommended [U]
B) Wait for 2 h after last dose
C) Wait for 12 h after last dose
D) Wait for 24 h after last dose
9.  A 58-yr-old white woman with known history of heparin-
induced thrombocytopenia takes fondaparinux because of a 
concomitant diagnosis of atrial fibrillation. She had a partial 
pancreatectomy after appropriate cessation of anticoagula-
tion in which a high thoracic epidural catheter was placed. 
How long after placement of the catheter is it safe to restart 
fondaparinux?
A)  Wait for at least 2 h after placement
B) Wait for at least 6 h after placement
C)  Fondaparinux is not recommended for patients 
with indwelling catheters [U]
D) Wait at least 24 h after placement
10.  A 57-yr-old Asian man presents for bilateral total knee 
replacements on consecutive days. The surgeon has 
requested an epidural be placed and remain in place through 
the second surgery. Your preoperative interview reveals the 
patient takes ginkgo biloba and garlic supplements for pro-
phylactic anticoagulation because of an aspirin allergy. He 
has taken these herbal supplements on the day of surgery. 
How long after taking these supplements can he have an 
epidural safely placed?
A) Wait for 2 h after taking garlic
B) Wait for 6 h after taking ginkgo biloba
C)  Proceed immediately as there is no significantly 
increased risk of hematoma [C]
D) Wait for 4 half-lives before placing neuraxial block
11.  A 23-yr-old African American woman with Factor V 
Leiden deficiency had a scheduled repeat cesarean section 
to orchestrate the timing of her anticoagulation. The case 
was performed under epidural because of the possibility of 
adhesions and extended duration. Normal coagulation was 
confirmed before the epidural placement. You are now in the 
recovery area after an uncomplicated surgical delivery, and 
you have just removed her epidural catheter. She has had a 
pulmonary embolism previously and thus is very anxious to 
restart her anticoagulation. How long until she may be safely 
dosed with prophylactic 30 mg enoxaparin subcutaneously 
twice daily?
A)  Restart immediately as her risk of deep vein thrombo-
sis and pulmonary embolism is very high
B)  Wait a minimum of 4 h after catheter removal for the 
first dose of low-molecular-weight heparin (LMWH)
C)  Wait a minimum of 24 h after surgery for the first 
dose of LMWH [C]
D)  Wait a minimum of 6 h after surgery for the first dose 
of LMWH
12.  A 55-yr-old African American male patient with infected total 
knee arthroplasty presents preoperatively for arthrotomy and 
hardware removal. Twelve hours ago, he required angioplasty 
and was started on eptifibatide until he can have definitive 
cardiac therapy after having his infected joint removed. The 
cardiologist stated that it was okay to hold the eptifibatide for 
surgery and that he would recommend avoiding general anes-
thesia for the case to avoid hemodynamic stress on his heart. 
The patient is also exceedingly anxious about general anes-
thesia and requests spinal anesthesia. As such, the case will 
be performed under subarachnoid block. How long should 
eptifibatide be held before performing the block?
A) Wait for at least 2 h
B) Wait for 4 to 8 h [U]
C) Wait for 12 h
D)  Subarachnoid block not recommended for patient on 
eptifibatide
13.  A 66-yr-old white man is admitted with necrotizing pancre-
atitis. The patient had a pulmonary embolism earlier in this 
hospitalization that has resolved. He was started on 30 mg 
enoxaparin subcutaneously twice daily. Pancreatic debride-
ment is scheduled for tomorrow, and the anesthetic plan 
includes a thoracic epidural for postoperative pain control. 
How long should the anesthesiologist wait to place the epi-
dural after the last preoperative enoxaparin dose?
A) Wait for at least 2 h
B) Wait for at least 6 h
C) Wait for at least 10 to 12 h [C]
D)  Neuraxial block is not recommended for patients on 
LMWH twice daily
14.  A 71-yr-old white woman with a prosthetic aortic valve pres-
ents for a left total hip arthroplasty. Anesthesia is planned 
with lumbar plexus catheter. Her warfarin was held for 5 
days. When can you safely place lumbar plexus catheter?
A)  The patient has been off warfarin long enough (5 
days); proceed with block
B)  Wait for at least 7 days and recheck international nor-
malized ratio (INR)
C) Proceed with block if INR has normalized [C]
D) Proceed with block if INR is less than 2.0
15.  A 72-yr-old Hispanic man is postoperative day 3 after a total knee 
replacement and has had excellent postoperative pain control 
with a lumbar epidural catheter. He is receiving 40 mg enoxaparin 
subcutaneously once daily. How long should you wait after 
administration of enoxaparin to remove the epidural catheter?
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A) 1 h
B) 2 h
C) 10 to 12 h [C]
D) 1 h before the next scheduled dose of enoxaparin
16.  A 25-yr-old otherwise healthy Asian woman athlete sched-
uled for knee reconstructive surgery desires to be awake dur-
ing the procedure. Her only medication is ibuprofen and she 
took 800 mg orally 12 h before surgery. The most appropriate 
action would be:
A)  Measure platelet function before any neuraxial tech-
nique is performed
B)  Wait for at least 3 half-lives of ibuprofen before per-
forming neuraxial technique
C)  Proceed and perform spinal anesthesia but do not 
perform epidural anesthesia
D) Proceed with spinal or epidural anesthesia [C]
17.  An orthopedic surgeon wants to use prophylactic daily doses 
of dalteparin subcutaneously for thromboprophylaxis after a 
hip replacement procedure. A continuous epidural catheter 
is used during the procedure in a 52-yr-old Indian man and 
is left in place overnight for pain control. When should the 
epidural catheter be removed in relation to dalteparin dosing?
A) At least 2 h before the first dose [U]
B) At least 2 h after the first dose
C) At least 12 h after the last dose
D)  At least 12 h after the last dose and after checking 
prothrombin time and partial thromboplastin time
18.  A 76-yr-old white man with peripheral vascular dis-
ease underwent femoral popliteal bypass with epidural 
anesthesia. The epidural was placed on the first attempt 
without complication. Postoperatively, the epidural catheter 
was removed after an appropriate time period after the last 
dose of systemic heparinization. How long must you wait 
until intravenous heparin can be safely restarted?
A) 1 h [C]
B) 2 h
C) 4 h
D) 12 h
19.  A 48-yr-old Asian woman with colon cancer underwent col-
ectomy 2 days ago. An epidural catheter that was placed pre-
operatively has provided excellent pain management but was 
just now removed. Enoxaparin 40 mg subcutaneously once 
daily has been used for deep vein thrombosis prophylaxis in 
the postoperative period. How long should you wait after epi-
dural catheter removal to restart enoxaparin?
A) May restart immediately
B) Minimum of 2 h [C]
C) Minimum of 4 h
D) Minimum of 10 h
20.  A 44-yr-old African American woman who is receiving 
unfractionated heparin (5,000 units subcutaneously twice 
daily) for deep vein thrombosis prophylaxis after total 
abdominal hysterectomy has a continuous epidural catheter 
in place and the surgeon asks that it be removed. The nurse 
just administered 5,000 units subcutaneously unfraction-
ated heparin. How long should you wait before removing 
the catheter?
A) Catheter can be removed immediately [C]
B) 2 h
C) 4 h
D) 12 h
Appendix 2: Number of Neuraxial and Regional Blocks Performed
Control (N = 137) eDST (N = 122)
Approximately how many neuraxial blocks (epidurals and subarachnoid blocks) have you performed?
  0–25 22 (16.1) 26 (21.3)
  26–50 14 (10.2) 10 (8.2)
  51–100 22 (16.1) 17 (13.9)
  101–150 17 (12.4) 15 (12.3)
  > 150 62 (45.3) 54 (44.3)
Approximately how many peripheral nerve blocks have you performed (including brachial and lumbar plexus)?
  0–25 41 (29.9) 34 (27.9)
  26–50 32 (23.4) 18 (14.8)
  51–100 21 (15.3) 23 (18.9)
  101–150 14 (10.2) 19 (15.6)
Data are represented as n (%).
eDST = electronic decision support tool.
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Guideline Adherence Improved by Decision Support
Appendix 3: Use of References and Confidence in Practice Concerning ASRA Guidelines
Control (N = 137) eDST (N = 122)
When presented with a patient on antithrombotic or thrombolytic therapy who is a potential candidate for neuraxial blockade, what 
reference do you utilize most frequently during preoperative evaluation to determine whether the patient is an appropriate candi-
date for block?
  Supervising faculty direction 28 (20.4) 25 (20.5)
  ASRA guidelines accessed on the web 74 (54.0) 68 (55.7)
  ASRA guidelines in hard copy 17 (12.4) 11 ( 9.0)
  Personal knowledge of ASRA guidelines 18 (13.1) 18 (14.8)
How often do you refer to the ASRA guidelines for regional or neuraxial anesthesia when evaluating patients for neuraxial blockade 
who are receiving antithrombotic or thrombolytic therapy?
  Very frequently 31 (22.6) 18 (14.8)
  Frequently 45 (32.8) 33 (27.0)
  Occasionally 33 (24.1) 43 (35.2)
  Rarely 20 (14.6) 21 (17.2)
  Never 8 ( 5.8) 7 ( 5.7)
I am confident in my ability to appropriately apply the ASRA guidelines in the patient receiving antithrombotic or thrombolytic therapy 
in the following conditions:
  When to place a neuraxial block
   Strongly disagree 5 ( 3.6) 4 (3.3)
   Disagree 8 ( 5.8) 7 (5.7)
   Undecided 9 ( 6.6) 16 (13.1)
   Agree 72 (52.6) 70 (57.4)
   Strongly agree 43 (31.4) 25 (20.5)
  When to remove a catheter
   Strongly disagree 2 ( 1.5) 2 ( 1.6)
   Disagree 9 ( 6.6) 15 (12.3)
   Undecided 18 (13.1) 21 (17.2)
   Agree 75 (54.7) 65 (53.3)
   Strongly agree 33 (24.1) 19 (15.6)
  When to restart antithrombotic medication after placing catheter
   Strongly disagree 3 ( 2.2) 1 (0.8)
   Disagree 12 ( 8.8) 22 (18.0)
   Undecided 37 (27.0) 34 (27.9)
   Agree 65 (47.4) 55 (45.1)
   Strongly agree 20 (14.6) 10 ( 8.2)
  When to restart antithrombotic medication after removing catheter
   Strongly disagree 3 ( 2.2) 1 (0.8)
   Disagree 16 (11.7) 25 (20.5)
   Undecided 33 (24.1) 30 (24.6)
   Agree 62 (45.3) 55 (45.1)
   Strongly agree 23 (16.8) 11 ( 9.0)
Data are represented as n (%).
ASRA = American Society of Regional Anesthesia and Pain Medicine; eDST = electronic decision support tool.
Appendix 4: Smartphone Familiarity and Frequency of Smartphone Use
Control (N = 137) eDST (N = 122)
How familiar are you with the use of a “smartphone” or “smart device”?
  Never used one before 2 (1.5) 0 (0.0)
  Some limited experience 9 (6.6) 7 (5.8)
  Very familiar with its use 126 (92.0) 114 (94.2)
How often do you use medical software or electronic cognitive aids on a smart phone or iPod?
  Never 18 (13.1) 14 (11.5)
  Monthly 19 (13.9) 22 (18.0)
  Weekly 40 (29.2) 35 (28.7)
  Daily or almost daily 60 (43.8) 51 (41.8)
Data are represented as n (%).
eDST = electronic decision support tool.
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